Wynne Elizabeth Patterson, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 51 E Main St, Avon, CT 06001 Phone: 860-404-2461 |
Silvina Vazquez Varela, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 93 Arch Rd, Avon, CT 06001 Phone: 917-804-8799 |
Mrs. Jaime Nicole Ricard, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 59 Waterville Rd, Avon, CT 06001 Phone: 860-674-8549 |
Swallowing Diagnostics, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-677-4048 |
Ms. Michelle Lenihan, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 90 Juniper Dr, Avon, CT 06001 Phone: 860-673-1664 |
Haley Marie Gustavson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Avon Meadow Ln, Avon, CT 06001 Phone: 860-284-9779 Fax: 860-409-4120 |
Ms. Rachel Candace Noia, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 203-895-9452 |
Sharon Vermilye Ruvane, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3 Haddam Dr, Avon, CT 06001 Phone: 860-404-7446 |
Toniane Picozzo, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-677-2934 |
Ms. Jenna Marie Tellerico Niles, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Avon Meadow Ln, Avon, CT 06001 Phone: 860-284-9779 Fax: 860-409-2190 |
Cheryl Rowe, MA/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-677-4048 |
Katrina Woodward, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-677-4048 Fax: 860-677-4048 |
Stephanie Kent Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 410-868-2426 |
Mrs. Jennifer Rucci, MA CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 Waterville Rd, Avon, CT 06001 Phone: 860-573-0120 |
Briana Jean Anderson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 163 Simsbury Rd Bldg 16, Avon, CT 06001 Phone: 860-608-7366 |
Sharon M Schloss, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 136 Simsbury Rd, Building 12, Avon, CT 06001 Phone: 860-284-9779 Fax: 860-409-2190 |
Speakology Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 35 Mountain View Ave, Avon, CT 06001 Phone: 860-608-7366 |
Makenna Calabrese, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 56 E Main St, Avon, CT 06001 Phone: 860-217-0098 |
Mrs. Courtney A Wengell, MA CCC - SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 51 E Main St, Avon, CT 06001 Phone: 860-404-2461 |
Elisabeth Sue Swanson, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 30 Avon Meadow Ln, Avon, CT 06001 Phone: 860-284-9779 Fax: 860-409-2190 |
News Archive
Innovative product development and technology consultancy firm Cambridge Consultants has collaborated with Clinigen Group to create a new way of identifying fresh market applications for drugs nearing the end of their product lifecycle.
EKF Molecular Diagnostics has agreed a collaboration with specialist medtech company ANGLE plc, to investigate the combination of ANGLE's Parsortix circulating tumour cell (CTC) harvesting platform with EKF Molecular's PointMan™ DNA enrichment technology as a liquid biopsy. If successful, the resulting simple blood test could enable the investigation of unexpected ultra-low level mutations in a patient's cancer for personalised cancer care.
Celgene Corporation today announced it has completed its acquisition of Abraxis BioScience, Inc. For each share of Abraxis common stock, Abraxis shareholders will receive (i) $58.00 in cash (ii) 0.2617 shares of Celgene common stock, and (iii) one tradeable Contingent Value Right (CVR), which entitles its holder to receive a pro rata share of potential payments for future regulatory milestones and commercial royalties.
BioSpecifics Technologies Corp., a biopharmaceutical company developing first in class collagenase-based products marketed as XIAFLEX in the U.S. and XIAPEX in Europe today announced its financial results for the third quarter ended September 30, 2011 and provided a corporate update. For the quarter, the Company reported net income of $0.3 million or $0.04 per share on a basic and on a fully diluted basis.
A team of geneticists at the Institut de recherches cliniques de Montr-al (IRCM), directed by Dr. Jacques Drouin, made an unexpected discovery on hormone secretion. Contrary to common belief, the researchers found that pituitary cells are organized in structured networks. The scientific breakthrough was published yesterday by the scientific journal Proceedings of the National Academy of Sciences.
› Verified 4 days ago